This is a rare inherited condition affecting the blood vessels in the lungs. It causes high blood pressure in the lungs, which can make it hard to breathe. It's passed down in families, but sometimes it happens without a known family history.
Every report comes from a Lived member, sent anonymously.
Have you tried Viagra (Sildenafil) for Familial Primary Pulmonary Hypertension?
Familial primary pulmonary hypertension is an inherited form of pulmonary arterial hypertension (PAH), a rare disease in which the small arteries inside the lungs gradually thicken and narrow. Blood has a harder time passing through them, so pressure builds up in the pulmonary arteries, the vessels that carry blood from the heart to the lungs. The right side of the heart, which pumps blood into the lungs, has to work harder against that pressure. Over time it can enlarge and weaken, and this strain on the right heart is what makes the disease serious. The early signs are easy to mistake for being out of shape or for asthma: breathlessness during activity, tiredness, dizziness or fainting, chest discomfort and, later, swelling in the ankles, legs or belly. Because these symptoms are so common, people often wait years for the right diagnosis. Today doctors usually call this condition heritable PAH. "Primary" was the older term for PAH with no other underlying disease, now called idiopathic PAH. Pulmonary hypertension is also an umbrella term: high lung pressure caused by left-sided heart disease, lung disease or old blood clots is a different problem with different treatment.
Most familial cases come from a change (variant) in a gene called BMPR2, which normally helps keep cell growth in the lining of small blood vessels in check. When it doesn't work properly, cells in the lung arteries overgrow and narrow the vessels. Several less common genes can do the same. Two of them, ACVRL1 and ENG, also cause hereditary hemorrhagic telangiectasia (HHT), an inherited disorder of fragile blood vessels, so some families have features of both conditions. The pattern is autosomal dominant: a parent who carries the variant has a 50% chance of passing it to each child. Carrying it does not mean developing PAH, though. Roughly 42% of women and 14% of men with a BMPR2 variant develop the disease, which is why it can seem to skip a generation. Researchers are still working out what tips some carriers into illness while others stay well. A gene change is found in most families with more than one affected relative, and in about 12 to 20% of people with no known family history. Separately from genetics, the former diet drugs fenfluramine and dexfenfluramine (withdrawn from the US market in 1997; fenfluramine is now used at low doses, as Fintepla, for certain childhood seizure disorders, with regular heart monitoring), cocaine and methamphetamine can cause PAH or add to risk.
Diagnosis usually starts with an echocardiogram, an ultrasound of the heart that estimates the pressure in the lungs and shows how well the right side of the heart is coping. Blood tests, an electrocardiogram (ECG), breathing tests, imaging of the lungs and scans for blood clots help rule out the more common causes of high lung pressure, such as heart or lung disease. The diagnosis is confirmed by right heart catheterization: a thin tube is passed through a vein into the right side of the heart to measure pressures directly. Normal average (mean) pressure in the pulmonary arteries is about 20 mmHg (millimeters of mercury, the same unit used for blood pressure readings) or lower. A mean pressure above 20 mmHg means pulmonary hypertension, and in PAH the measurements also show that the resistance lies in the lung vessels themselves rather than in a backed-up left heart. During the same procedure, doctors may test whether the vessels relax in response to a short-acting medicine, which identifies the small group who may respond to calcium channel blockers. Genetic testing with a panel of PAH genes is recommended for people with familial or unexplained PAH, ideally with a genetic counselor. Finding the family variant lets relatives choose whether to be tested themselves.
There is no cure for PAH, but treatment has changed considerably and can relieve symptoms, improve how far a person can walk and slow the disease. Care is best led by a specialist pulmonary hypertension center. Most PAH medicines relax the narrowed lung arteries and ease the load on the heart by acting on chemical signals that control them. Many people start with two medicines together, usually an endothelin receptor antagonist such as ambrisentan or macitentan plus a phosphodiesterase-5 (PDE5) inhibitor such as sildenafil (Revatio) or tadalafil, because starting with a combination works better than one drug alone. People at higher risk, or who are not improving, add a prostacyclin-type medicine. These range from pills (such as selexipag) to inhaled treprostinil and continuous infusions given under the skin or into a vein through a small portable pump. Infusions are the most powerful option but require careful daily care of the line. Sotatercept (Winrevair), a newer injection given every three weeks, works through a different pathway from the other medicines; added to other treatment it improves exercise capacity and reduces the risk of hospitalization and worsening. It requires regular blood counts because it can raise red blood cell levels and lower platelets, and bleeding can occur. A small minority whose vessels relax during catheterization testing may do well on high doses of calcium channel blockers, but only under close specialist follow-up. Supportive care includes diuretics (water pills) for fluid buildup, oxygen when blood oxygen is low, and supervised exercise or pulmonary rehabilitation, which can improve stamina and quality of life. For people whose disease progresses despite full treatment, lung transplantation is an option, and referral is best considered early.
PAH is a long-term condition, and its course varies a great deal. Some people stay stable for years on oral medicines, while others need treatment stepped up to infusions or eventually a transplant. Outlook tends to be better when the disease is found early and treatment brings a person to a low-risk status, which is why regular follow-up matters. Checkups typically include a six-minute walk test, a blood test called NT-proBNP that reflects strain on the heart, and echocardiograms. Together these results set a person's risk level, and treatment is adjusted with the aim of reaching low risk. Daily life often involves pacing activity, limiting salt to control fluid, staying up to date on flu and pneumonia vaccines, and planning ahead for air travel or high altitude, where lower oxygen can strain the heart. Pregnancy carries a high, potentially life-threatening risk with PAH and is generally advised against. Several PAH medicines, including endothelin receptor antagonists and sotatercept, can harm a developing baby, so reliable contraception and early planning conversations are part of care. Because the condition is inherited, it also affects the family. Relatives who carry the variant are usually advised to have regular screening, ideally once a year, with echocardiograms, blood tests and symptom reviews, so that PAH is caught early if it develops. Some people choose not to be tested, and that is a valid decision. Genetic counselors can help with these choices, including questions about children, family planning and life or disability insurance, which genetic discrimination laws may not fully cover.
See a doctor if you have breathlessness, fatigue or fainting that is new or out of proportion to your activity, especially if a relative has PAH or carries a PAH gene variant. Relatives who are being screened should not wait for the next scheduled visit if breathlessness appears. If you already have PAH, contact your specialist team promptly when you notice increasing breathlessness, new swelling in the legs or belly, dizziness, fainting or streaks of blood when you cough, or if you think you may be pregnant. If you use a continuous infusion pump, even a brief interruption can make symptoms return quickly, so call your care team right away if the pump stops or the line is damaged or blocked. Call 911 if you cough up more than a few teaspoons of blood, since bleeding in the lungs is a serious complication of PAH, or for chest pain with shortness of breath, which can signal a heart attack or a blood clot in the lungs.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Familial Primary Pulmonary Hypertension is like, what's helped you, or ask the community a question.